Pediatrix Medical EBITDA Margin 2010-2025 | MD
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Pediatrix Medical (MD) over the last 10 years. The current EBITDA margin for Pediatrix Medical as of March 31, 2025 is .
| Pediatrix Medical EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $1.98B | $-0.02B | -1.22% |
| 2024-12-31 | $2.01B | $-0.04B | -1.79% |
| 2024-09-30 | $2.01B | $-0.03B | -1.50% |
| 2024-06-30 | $2.00B | $-0.02B | -1.00% |
| 2024-03-31 | $2.00B | $0.03B | 1.60% |
| 2023-12-31 | $2.00B | $0.05B | 2.26% |
| 2023-09-30 | $2.01B | $0.19B | 9.59% |
| 2023-06-30 | $2.00B | $0.20B | 10.02% |
| 2023-03-31 | $1.98B | $0.20B | 10.15% |
| 2022-12-31 | $1.97B | $0.21B | 10.65% |
| 2022-09-30 | $1.96B | $0.24B | 12.31% |
| 2022-06-30 | $1.96B | $0.25B | 12.91% |
| 2022-03-31 | $1.95B | $0.25B | 12.99% |
| 2021-12-31 | $1.91B | $0.24B | 12.55% |
| 2021-09-30 | $1.83B | $0.21B | 11.26% |
| 2021-06-30 | $1.80B | $0.17B | 9.23% |
| 2021-03-31 | $1.74B | $0.15B | 8.62% |
| 2020-12-31 | $1.73B | $0.13B | 7.73% |
| 2020-09-30 | $1.78B | $0.14B | 7.88% |
| 2020-06-30 | $1.77B | $0.15B | 8.59% |
| 2020-03-31 | $1.92B | $0.18B | 9.24% |
| 2019-12-31 | $2.33B | $0.26B | 11.09% |
| 2019-09-30 | $1.02B | $0.09B | 9.18% |
| 2019-06-30 | $1.42B | $0.18B | 12.76% |
| 2019-03-31 | $1.72B | $0.26B | 14.92% |
| 2018-12-31 | $1.72B | $0.28B | 16.13% |
| 2018-09-30 | $3.27B | $0.50B | 15.18% |
| 2018-06-30 | $3.29B | $0.52B | 15.85% |
| 2018-03-31 | $3.27B | $0.53B | 16.11% |
| 2017-12-31 | $3.25B | $0.54B | 16.56% |
| 2017-09-30 | $3.38B | $0.60B | 17.88% |
| 2017-06-30 | $3.34B | $0.63B | 18.96% |
| 2017-03-31 | $3.27B | $0.65B | 19.99% |
| 2016-12-31 | $3.18B | $0.67B | 20.89% |
| 2016-09-30 | $3.10B | $0.67B | 21.49% |
| 2016-06-30 | $2.99B | $0.65B | 21.81% |
| 2016-03-31 | $2.89B | $0.64B | 22.11% |
| 2015-12-31 | $2.78B | $0.62B | 22.45% |
| 2015-09-30 | $2.69B | $0.61B | 22.72% |
| 2015-06-30 | $2.59B | $0.59B | 22.78% |
| 2015-03-31 | $2.51B | $0.57B | 22.84% |
| 2014-12-31 | $2.44B | $0.56B | 22.91% |
| 2014-09-30 | $2.36B | $0.54B | 22.79% |
| 2014-06-30 | $2.28B | $0.52B | 22.85% |
| 2014-03-31 | $2.22B | $0.51B | 22.78% |
| 2013-12-31 | $2.15B | $0.49B | 22.84% |
| 2013-09-30 | $2.06B | $0.47B | 22.79% |
| 2013-06-30 | $1.98B | $0.45B | 22.77% |
| 2013-03-31 | $1.90B | $0.43B | 22.88% |
| 2012-12-31 | $1.82B | $0.42B | 23.12% |
| 2012-09-30 | $1.75B | $0.41B | 23.30% |
| 2012-06-30 | $1.69B | $0.39B | 23.37% |
| 2012-03-31 | $1.63B | $0.39B | 23.70% |
| 2011-12-31 | $1.59B | $0.38B | 23.99% |
| 2011-09-30 | $1.55B | $0.37B | 24.11% |
| 2011-06-30 | $1.49B | $0.36B | 24.16% |
| 2011-03-31 | $1.45B | $0.35B | 24.07% |
| 2010-12-31 | $1.40B | $0.34B | 23.91% |
| 2010-09-30 | $1.37B | $0.33B | 23.94% |
| 2010-06-30 | $1.35B | $0.32B | 23.85% |
| 2010-03-31 | $1.32B | $0.31B | 23.77% |
| 2009-12-31 | $1.29B | $0.31B | 23.76% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.101B | $2.013B |
| Pediatrix Medical Group Inc. is a national medical group comprised of physician services practicing under the Pediatrix(R) brand. It provides services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Pediatrix Medical Group Inc., formerly known as Mednax Inc., is based in FORT LAUDERDALE, Fla. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $138.339B | 25.95 |
| CVS Health (CVS) | United States | $80.708B | 10.03 |
| Elevance Health (ELV) | United States | $77.846B | 10.05 |
| Cencora (COR) | United States | $57.726B | 20.08 |
| DiDi Global (DIDIY) | China | $28.851B | 30.65 |
| Labcorp Holdings (LH) | United States | $20.589B | 16.70 |
| Natera (NTRA) | United States | $20.264B | 0.00 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.895B | 0.00 |
| CochLear (CHEOY) | Australia | $12.835B | 0.00 |
| Solventum (SOLV) | United States | $12.635B | 13.38 |
| ICON (ICLR) | Ireland | $11.632B | 10.81 |
| Revvity (RVTY) | United States | $11.186B | 19.25 |
| Viatris (VTRS) | United States | $10.657B | 3.66 |
| Medpace Holdings (MEDP) | United States | $9.049B | 24.03 |
| Sonic Healthcare (SKHHY) | Australia | $8.827B | 0.00 |
| Avantor (AVTR) | United States | $8.763B | 12.73 |
| HealthEquity (HQY) | United States | $8.446B | 37.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.988B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.610B | 14.91 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.943B | 29.10 |
| BrightSpring Health Services (BTSG) | United States | $3.527B | 32.35 |
| Sotera Health (SHC) | United States | $3.188B | 18.11 |
| Surgery Partners (SGRY) | United States | $2.902B | 37.73 |
| Alignment Healthcare (ALHC) | United States | $2.649B | 0.00 |
| Concentras Parent (CON) | United States | $2.522B | 14.58 |
| Organon (OGN) | United States | $2.503B | 2.66 |
| GeneDx Holdings (WGS) | United States | $2.296B | 88.43 |
| Progyny (PGNY) | United States | $1.973B | 43.43 |
| PACS (PACS) | United States | $1.882B | 0.00 |
| Premier (PINC) | United States | $1.730B | 13.13 |
| Ardent Health (ARDT) | United States | $1.718B | 7.32 |
| GoodRx Holdings (GDRX) | United States | $1.700B | 34.00 |
| Teladoc Health (TDOC) | United States | $1.382B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.263B | 0.00 | |
| CareDx (CDNA) | United States | $1.069B | 16.70 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.894B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.848B | 291.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.754B | 7.06 |
| InnovAge Holding (INNV) | United States | $0.590B | 0.00 |
| Nutex Health (NUTX) | United States | $0.578B | 8.75 |
| Embecta (EMBC) | United States | $0.570B | 3.84 |
| SBC Medicals (SBC) | United States | $0.543B | 0.00 |
| So-Young (SY) | China | $0.530B | 0.00 |
| LifeMD (LFMD) | United States | $0.514B | 0.00 |
| Omada Health (OMDA) | $0.476B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.474B | 10.67 |
| Sonida Senior Living (SNDA) | United States | $0.473B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.368B | 0.00 |
| Enhabit (EHAB) | United States | $0.346B | 28.50 |
| Performant Healthcare (PHLT) | United States | $0.318B | 0.00 |
| Oncology Institute (TOI) | United States | $0.288B | 0.00 |
| Beauty Health (SKIN) | United States | $0.217B | 0.00 |
| DocGo (DCGO) | United States | $0.145B | 23.67 |
| Pheton Holdings (PTHL) | China | $0.138B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.112B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.074B | 0.00 |
| KindlyMD (NAKA) | United States | $0.069B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.060B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.050B | 0.00 |
| Biodesix (BDSX) | United States | $0.045B | 0.00 |
| ModivCare (MODV) | United States | $0.042B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |